Back

PRIME Education, Inc. (PRIME®)

  • Immune Checkpoint Inhibitors
  • Melanoma

Advancing Immune Checkpoint Inhibitor Use in Resectable Melanoma

This on-demand video podcast features expert insights from a dermatologist and medical oncologist on the evolving role of immune checkpoint inhibitors in resectable melanoma. Faculty will review the latest evidence supporting neoadjuvant and adjuvant strategies, offering practical approaches to treatment planning in real-world settings. Through case-based discussions, the program explores how to individualize therapy based on stage, recurrence risk, and individual patient characteristics, while addressing best practices in immune-related adverse event management. Emphasizing the importance of multidisciplinary collaboration, this activity provides actionable guidance to advance evidence-based, personalized care and improve long-term outcomes.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 0.5 creditsAAPA Category 1 Credit™Up to 0.5 creditsAMA PRA Category 1 Credit™Up to 0.5 creditsNursingUp to 0.5 creditsPharmacyUp to 0.5 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Podcast / audio
  • includes Case-based learning
  • includes On-demand / recorded video
  • Credit · Up to 0.5 credits
  • Commercial Support
  • Released
    Nov 18, 2025
  • Last day to claim credit
    Nov 18, 2026 5 weeks left